Metastatic Colorectal Cancers Completed Phase 3 Trials for Leucovorin (DB00650)

Also known as: Colorectal cancer metastatic / Metastatic Colorectal Cancer

IndicationStatusPhase
DBCOND0063579 (Metastatic Colorectal Cancers)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00252564Cetuximab, Bevacizumab & 5FU/Leucovorin vs. Oxaliplatin, Bevacizumab & 5FU/Leucovorin in Metastatic Colorectal CancerTreatment
NCT01670721Colorectal Cancer MetastaticTreatment
NCT01228734A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy (FOLFOX-4) With or Without Cetuximab in the 1st Line Treatment of Metastatic Colorectal Cancer (mCRC) in Chinese Rat Sarcoma Viral Oncogene Homolog (RAS) Wild-type PatientsTreatment
NCT03288987A Clinical Trial to Evaluate the Efficacy and Safety of Bevacizumab (AryoGen Pharmed) Compared With Bevacizumab (Avastin®) in Metastatic Colorectal CancerTreatment
NCT00145314FLOX in Combination With Cetuximab in First-line Treatment of Colorectal CancerTreatment
NCT00399035Cediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal CancerTreatment
NCT00457691Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal CancerTreatment
NCT01030042Trial Comparing Two Two Sequences of Therapy in Colorectal Metastatic PatientsTreatment
NCT01219920FOLFOXIRI Compared With FOLFIRI for Metastatic Colorectal CancerTreatment